Have a personal or library account? Click to login
Effectiveness of Botulinum Toxin on Hand Tremor Intensity and Upper Limb Function in Patients with Parkinson’s Disease: Results of a Systematic Review Cover

Effectiveness of Botulinum Toxin on Hand Tremor Intensity and Upper Limb Function in Patients with Parkinson’s Disease: Results of a Systematic Review

Tremor and Other Hyperkinetic Movements
Volume 13 (2023): Issue 1
By: Fariba Eslamian,  Neda Dolatkhah,  Leila Fallah,  Fatemeh Jahanjoo,  Vahideh Toopchizadeh and  Mahnaz Talebi  
Open Access
|Aug 2023

References

  1. 1Poewe W, Seppi K, Tanner CM, et al. Parkinson disease. Nature reviews Disease primers. Mar 23 2017; 3: 17013. DOI: 10.1038/nrdp.2017.13
    Back to article
  2. 2Sveinbjornsdottir S. The clinical symptoms of Parkinson’s disease. J Neurochem. 2016; 139: 318–324. DOI: 10.1111/jnc.13691
    Back to article
  3. 3Tarakad A, Jankovic J. Diagnosis and management of Parkinson’s disease. Thieme Medical Publishers; 2017: 118–126. DOI: 10.1055/s-0037-1601888
    Back to article
  4. 4Hallett M. Parkinson’s disease tremor: pathophysiology. Parkinsonism & related disorders. Jan 2012; 18(Suppl 1): S85–6. DOI: 10.1016/S1353-8020(11)70027-X
    Back to article
  5. 5Louis ED. Tremor. CONTINUUM: Lifelong Learning in Neurology. 2019; 25(4): 959–975. DOI: 10.1212/CON.0000000000000748
    Back to article
  6. 6Bhatia KP, Bain P, Bajaj N, et al. Consensus Statement on the classification of tremors. from the task force on tremor of the International Parkinson and Movement Disorder Society. Mov Disord. 2018; 33(1): 75–87. DOI: 10.1002/mds.27121
    Back to article
  7. 7Rahimi F, Debicki D, Roberts-South A, Bee C, Bapat P, Jog M. Dynamic decomposition of motion in essential and parkinsonian tremor. Canadian Journal of Neurological Sciences. 2015; 42(2): 116–124. DOI: 10.1017/cjn.2015.12
    Back to article
  8. 8Fasano A, Lozano AM, Cubo E. New neurosurgical approaches for tremor and Parkinson’s disease. Curr Opin Neurol. 2017; 30(4): 435–446. DOI: 10.1097/WCO.0000000000000465
    Back to article
  9. 9Zakin E, Simpson D. Botulinum toxin in management of limb tremor. Toxins. 2017; 9(11): 365. DOI: 10.3390/toxins9110365
    Back to article
  10. 10Jankovic J. An update on new and unique uses of botulinum toxin in movement disorders. Toxicon. 2018; 147: 84–88. DOI: 10.1016/j.toxicon.2017.09.003
    Back to article
  11. 11Jankovic J. Botulinum toxin: State of the art. Movement Disorders. 2017; 32(8): 1131–1138. DOI: 10.1002/mds.27072
    Back to article
  12. 12Andringa A, van de Port I, van Wegen E, Ket J, Meskers C, Kwakkel G. Effectiveness of botulinum toxin treatment for upper limb spasticity poststroke over different ICF domains: a systematic review and meta-analysis. Arch Phys Med Rehabil. 2019; 100(9): 1703–1725. DOI: 10.1016/j.apmr.2019.01.016
    Back to article
  13. 13Hallett M, Albanese A, Dressler D, et al. Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders. Toxicon. 2013; 67: 94–114. DOI: 10.1016/j.toxicon.2012.12.004
    Back to article
  14. 14Eleopra R, Rinaldo S, Montecucco C, Rossetto O, Devigili G. Clinical duration of action of different botulinum toxin types in humans. Toxicon. 2020; 179: 84–91. DOI: 10.1016/j.toxicon.2020.02.020
    Back to article
  15. 15Mittal SO, Lenka A, Jankovic J. Botulinum toxin for the treatment of tremor. Parkinsonism & related disorders. 2019; 63: 31–41. DOI: 10.1016/j.parkreldis.2019.01.023
    Back to article
  16. 16Cardoso F. Botulinum toxin in parkinsonism: The when, how, and which for botulinum toxin injections. Toxicon. 2018; 147: 107–110. DOI: 10.1016/j.toxicon.2017.08.018
    Back to article
  17. 17Anandan C, Jankovic J. Botulinum toxin in movement disorders: an update. Toxins. 2021; 13(1): 42. DOI: 10.3390/toxins13010042
    Back to article
  18. 18Higgins JP, Green S. Cochrane handbook for systematic reviews of interventions 5.1. 0. The Cochrane Collaboration. 2011; 33–49.
    Back to article
  19. 19Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Annals of internal medicine. 2009; 151(4): 264–269. DOI: 10.7326/0003-4819-151-4-200908180-00135
    Back to article
  20. 20Samotus O, Lee J, Jog M. Long-term tremor therapy for Parkinson and essential tremor with sensor-guided botulinum toxin type A injections. PLoS One. 2017; 12(6): e0178670. DOI: 10.1371/journal.pone.0178670
    Back to article
  21. 21Pullman SL, Greene P, Fahn S, Pedersen SF. Approach to the treatment of limb disorders with botulinum toxin A: experience with 187 patients. Archives of neurology. 1996; 53(7): 617–624. DOI: 10.1001/archneur.1996.00550070055012
    Back to article
  22. 22Rahimi F, Bee C, Debicki D, Roberts AC, Bapat P, Jog M. Effectiveness of BoNT A in Parkinson’s disease upper limb tremor management. Can J Neurol Sci. 2013; 40(5): 663–669. DOI: 10.1017/S031716710001489X
    Back to article
  23. 23Rahimi F, Samotus O, Lee J, Jog M. Effective management of upper limb parkinsonian tremor by incobotulinumtoxinA injections using sensor-based biomechanical patterns. Tremor Other Hyperkinetic Movements. 2015; 5. DOI: 10.5334/tohm.240
    Back to article
  24. 24Mittal SO, Machado D, Richardson D, Dubey D, Jabbari B. Botulinum toxin in Parkinson disease tremor: a randomized, double-blind, placebo-controlled study with a customized injection approach. Elsevier. 2017; 1359–1367. DOI: 10.1016/j.mayocp.2017.06.010
    Back to article
  25. 25Jankovic J, Schwartz K. Botulinum toxin treatment of tremors. Neurology. 1991; 41(8): 1185–1185. DOI: 10.1212/WNL.41.8.1185
    Back to article
  26. 26Trosch R, Pullman S. Botulinum toxin A injections for the treatment of hand tremors. Movement disorders: official journal of the Movement Disorder Society. 1994; 9(6): 601–609. DOI: 10.1002/mds.870090604
    Back to article
  27. 27Henderson J, Ghika J, Van Melle G, Haller E, Einstein R. Botulinum toxin A in non-dystonic tremors. European neurology. 1996; 36(1): 29–35. DOI: 10.1159/000117196
    Back to article
  28. 28Niemann N, Jankovic J. Botulinum toxin for the treatment of hand tremor. Toxins. 2018; 10(7): 299. DOI: 10.3390/toxins10070299
    Back to article
  29. 29Kreisler A, Bouchain B, Defebvre L, Krystkowiak P. Treatment with botulinum neurotoxin improves activities of daily living and quality of life in patients with upper limb tremor. Tremor Other Hyperkinetic Movements. 2019; 9. DOI: 10.5334/tohm.458
    Back to article
  30. 30Mittal SO, Jog M, Lee J, Jabbari B. Novel Botulinum Toxin Injection Protocols for Parkinson Tremor and Essential Tremor - the Yale Technique and Sensor-Based Kinematics Procedure for Safe and Effective Treatment. Tremor and other hyperkinetic movements (New York, NY). Dec 31 2020; 10: 61. DOI: 10.5334/tohm.582
    Back to article
  31. 31Mittal SO, Machado D, Richardson D, Dubey D, Jabbari B. Botulinum toxin in essential hand tremor-A randomized double-blind placebo-controlled study with customized injection approach. Parkinsonism & related disorders. 2018; 56: 65–69. DOI: 10.1016/j.parkreldis.2018.06.019
    Back to article
  32. 32Martínez-Martín P, Rodríguez-Blázquez C, Alvarez M, et al. Parkinson’s disease severity levels and MDS-Unified Parkinson’s Disease Rating Scale. Parkinsonism related disorders. 2015; 21(1): 50–54. DOI: 10.1016/j.parkreldis.2014.10.026
    Back to article
  33. 33Lakraj A-AD, Moghimi N, Jabbari B. Hyperhidrosis: anatomy, pathophysiology and treatment with emphasis on the role of botulinum toxins. Toxins. 2013; 5(4): 821–840. DOI: 10.3390/toxins5040821
    Back to article
  34. 34Baricich A, Picelli A, Santamato A, et al. Safety Profile of High-Dose Botulinum Toxin Type A in Post-Stroke Spasticity Treatment. Clinical drug investigation. Nov 2018; 38(11): 991–1000. DOI: 10.1007/s40261-018-0701-x
    Back to article
  35. 35Kamel JT, Cordivari C, Catania S. Treatment of upper limb tremor with botulinum toxin: an individualized approach. Movement disorders clinical practice. 2019; 6(8): 652–655.DOI: 10.1002/mdc3.12832
    Back to article
  36. 36Mor N, Tang C, Blitzer A. Temporomandibular myofacial pain treated with botulinum toxin injection. Toxins. 2015; 7(8): 2791–2800. DOI: 10.3390/toxins7082791
    Back to article
  37. 37Yadav S, Chand S, Majumdar R, Sud A. Effect of botulinum toxin type-A in spasticity and functional outcome of upper limbs in cerebral palsy. Journal of clinical orthopaedics and trauma. 2020; 11(2): 208–212. DOI: 10.1016/j.jcot.2020.01.002
    Back to article
  38. 38Andringa A, van de Port I, van Wegen E, Ket J, Meskers C, Kwakkel G. Effectiveness of botulinum toxin treatment for upper limb spasticity poststroke over different ICF domains: a systematic review and meta-analysis. Archives of physical medicine and rehabilitation. 2019; 100(9): 1703–1725. DOI: 10.1016/j.apmr.2019.01.016
    Back to article
DOI: https://doi.org/10.5334/tohm.773 | Journal eISSN: 2160-8288
Journal RSS Feed
Language: English
Submitted on: Apr 15, 2023
Accepted on: Aug 10, 2023
Published on: Aug 24, 2023
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
Botulinum toxin,
Parkinson’s disease,
the unified Parkinson’s disease rating scale,
Tremor

© 2023 Fariba Eslamian, Neda Dolatkhah, Leila Fallah, Fatemeh Jahanjoo, Vahideh Toopchizadeh, Mahnaz Talebi, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 13 (2023): Issue 1Next article